tert-Butyl 9-oxo-7-oxa-3,10-diazaspiro[5.6]dodecane-3-carboxylate

Catalog No.: 
ACPYXK461
CAS No.: 
1179338-64-7
Molecular Formula: 
C14H24N2O4
Molecular Weight: 
284.36
tert-Butyl 9-oxo-7-oxa-3,10-diazaspiro[5.6]dodecane-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$337.00In stockInquiry
250mg95%$536.00In stockInquiry
500mg95%$895.00In stockInquiry
1g95%$1340.00In stockInquiry
5g95%$4020.00InquiryInquiry
10g95%$6700.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl 9-oxo-7-oxa-3,10-diazaspiro[5.6]dodecane-3-carboxylate
IUPAC Nametert-butyl 9-oxo-7-oxa-3,10-diazaspiro[5.6]dodecane-3-carboxylate
MDL No.MFCD25542342
Molecular FormulaC14H24N2O4
Molecular Weight284.36
SMILESO=C(N1CCC2(OCC(NCC2)=O)CC1)OC(C)(C)C
InChI KeyGGZHKXRNPQSVED-UHFFFAOYSA-N
Synonymtert-butyl 9-oxo-7-oxa-3,10-diazaspiro[5.6]dodecane-3-carboxylate;7-Oxa-3,10-diazaspiro[5.6]dodecane-3-carboxylic acid, 9-oxo-, 1,1-dimethylethyl ester;3-Boc-9-oxo-7-oxa-3,10-diazaspiro[5.6]dodecane
CAS No.1179338-64-7

Synthetic Route by SureRoute

1. ACPYXK461 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPYXK461 route product structure diagram
    ACPYXK4611179338-64-7In Stock
Inquiry

2. ACPYXK461 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPYXK461 route product structure diagram
    ACPYXK4611179338-64-7In Stock
Inquiry

3. ACPYXK461 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPYXK461 route product structure diagram
    ACPYXK4611179338-64-7In Stock
Inquiry

Comments (0)